The most commonly reported concerns were pain 18/59 (31%), fatigue 14/59 (24%), sexual function 14/59 (24%) and sleep disturbance 11/59 (19%). Second primary malignancies were recorded in five cases. Implementation and audit of the international late effect screening guidelines confirm the need for systematic long-term physical and psychological screening and care, thus ensuring timely and efficient identification of problems and the opportunity to minimise morbidity effects and optimise health.
approach to screening guidance and recommendations, alongside specific and common late effects of HCT, was published in 2012 (Majhail et al., 2012) and adapted for clinical use in our transplant centre with systematic screening coordinated through a nurse-led late effects clinic. Thus, the aims of our clinical audit were:
1. To evaluate the clinical efficacy of the screening clinic to identify late effects following HCT.
2.
To evaluate the number and nature of subsequent actions or referrals.
| PARTICIPANTS AND METHODS
Our centre implemented the internationally agreed guidelines in 2013 using a locally developed Standardised Operating Policy (SOP) through a nurse-led late effects screening clinic. 59 consecutive patients who attended the screening clinic for the first time during 1 September 2013 to 31 August 2014 were included in the audit. Suitable patients were referred into the clinic by the transplant physicians in the same institution.
Patients were in remission, with no active GVHD and without infection.
The late effects screening clinic was held in an out patients facility and run in parallel to the consultant led transplant clinics. Audit approval confirmation was given by the Clinical Effectiveness Unit of our hospital trust.
Data were extracted from the clinic letter annotated from the consultation and from results of the requested investigations as per the SOP.
Presence or absence of each variable and investigation was coded and current results and actions were recorded in a spreadsheet. The accuracy of requesting investigations as per the departmental SOP was reviewed to check whether these results were deranged or within normal limits.
| RESULTS

| Demographics
Thirty patients were female and 29 male. Fifty-four patients received one transplant, four had two transplants and one had three transplants. 49/65 (75%) of transplants were allogeneic. Primary indications for HCT for audit participants are given in Figure 1 . Mean age of patients at assessment was 49 years (range 22-74), mean years from initial diagnosis was 8 (range 1-28) and mean years since transplant was 6 (0.5-18).
Forty-four of 59 (75%) had chemotherapy treatment prior to transplant with 12 of these having further high dose treatments. The most widely used chemotherapy regimen was FLAG-Ida (n = 8). Thirteen patients had TBI radiotherapy as part of their conditioning. Fifty-one patients were given pre-transplant conditioning regimens with eight patients not recorded as having conditioning. Thirteen of 59 received biological therapy, most receiving interferon (n = 5) or rituximab (n = 5).
The most commonly identified health problems are given in Table 1 .
| Health problems by system
| Skin
Nine patients reported skin concerns including dryness or rash.
Seven had documented referrals for further review by the consultant in charge of the screening clinic or to the GP for monitoring of skin lesions.
| Head, eyes, ears nose and throat
Ten patients suffered ocular complications mainly with dry eyes or "gritty eyes." Ocular action was documented for 16 people, i.e. were recommended an optician appointment for routine eye testing or referred to an ophthalmologist for specialist review.
Thirteen patients reported oral complications mainly of xerostomia (dry mouth). Action or referral was documented in 11, one being advised a routine dental appointment, two needing no further action and one who had no action documented.
| Respiratory system
Seven patients reported respiratory problems, principally chest infections and coughs, and five further action documented. Fifty-seven had recorded pulmonary function tests (PFTs) requested as part of routine post-HCT screening. Reported results indicated 21 had low TLCO, three low FEV1 and four with both low FEV1 and TLCO.
| Cardiovascular system
Thirteen cases of elevated blood pressure were recorded with eight cases identified in clinic and five pre-existing. Three patients were found to have cardiac complications and all were referred to a cardiologist for specialist review. Fifty six had recorded echocardiogram F I G U R E 1 Primary indications for HCT for audit participants reports, of which 49 were reported to have good systolic function with 22 reports of mild problems such as aortic regurgitation.
Thirty of 47 patients who had lipids evaluated had deranged results, with one report of further action. Of these, 23 had elevated triglycerides but no recorded further actions.
| Gastrointestinal system
Two patients reported upper GI complications such as suspected silent reflux and excess gastric acid. Action was recorded for both patients.
Six patients suffered lower GI complications, predominantly diarrhoea and urgent defecation -of these five had documented action. Forty one had liver function tests performed, 11 results were deranged, but no further action documented.
| Genital system
Fourteen patients reported problems with sexual function with 13 being referred for further investigation/specialist advice. Reports of four patients with early menopause as a result of HCT were documented, three had documented action or referral. One man identified with testosterone deficiency, was referred to an endocrinologist.
| Neurological system
Six patients prioritised memory loss as a major concern, however, no specific actions were documented. Fourteen patients reported persistent fatigue. Seven had documentation of further action such as referral to a specialist. All patients would normally have repeat bloods to exclude organic causes. Low energy, tiredness and sleep problems were the main concern of patients when asked to prioritise concerns; 20 experienced difficulties with sleepiness and fluctuating energy levels, 11 reported problems sleeping at night of these -7/11 had documentation of action.
Eighteen patients reported pain. The plan of action for pain management was documented although two patients had no further action documented.
| Musculo-skeletal system
DEXA scans results were available in 17/59 patients. Four patients were found to have low bone mineral density with further action being to evaluate specific problems and consider supplementation of 
| Haematological system
Eighteen of 24 patients were found to have high ferritin levels. Two had reported evidence of further action (venesections) being taken.
Twenty had vitamin B12 levels tested, two of these were deranged but no action was documented.
| Endocrine system
TSH was measured in 48 patients, resulting in 12 deranged results and one documented referral/action.
| Immunology system
Thirty letters mentioned vaccination programmes with evidence of 23/30 having a reported plan such as recommending an annual flu jab or requests for GP reinstatement of vaccine programmes which may have been paused to manage GVHD. Five patients experienced complications from a compromised immune system -predominantly GVHD, recurrent chest infections and multiple infections varying from sinusitis to UTI. All actions were documented -often the problem was already managed by other specialists but those with recurrent infections required further investigations.
| Psychological system
Six patients were referred to a psychologist with an additional one patient who was recommended to see a psychologist and one referred to a psychiatrist.
| Malignancies
Six malignancies were recorded post-transplantation of which five were recent onset primary skin lesions and the other new malignancy was liver metastases from previous colon cancer. 
| DISCUSSION
To our knowledge, this is the first time the new international late effect screening guidelines have been formally audited (Majhail et al., 2012) . One hundred and thirty four new problems or concerns were identified in 59 consecutive transplant patients with 114 documented further action or referrals. The most frequently concerns were pain, fatigue, sexual function and sleep patterns. Second malignancy was reported in five cases.
Pain is a well-recognised unmet need of cancer patients (Vogelzang et al., 1997) and also evident in HCT patients (Niscola et al., 2008) . Pain is often associated with fatigue with 30%-42% of HCT survivors troubled by fatigue in contrast to <20% prevalence of pain (Mosher et al., 2011) . Interestingly, Vogelzang et al. (1997) found that whilst oncologists believed that pain affected their patients to a higher degree than fatigue, patients believed that fatigue affected their lives more daily than pain (61% versus 19%). The reported sources of pain are mainly due to the mucosal tissue injury induced by the conditioning regimen but also include pain from infection, from acute or chronic GVHD as well as adverse drug reactions to GVHD drug prophylaxis. Furthermore, some late complications of the actual transplant may be associated with pain (Niscola et al., 2008) . The management strategy of pain that is recommended is using the analgesic ladder -NSAIDs or paracetamol for mild pain, partial mixed opiate receptor agonists and mild opioids, e.g. oxycodone for moderate pain relief and finally, the pure μ-opiate receptor agonists or strong opioids, e.g. morphine and fentanyl, are chosen for severe pain relief. With one third of our cohort reporting pain as an issue, there is a clear need for regular assessment and monitoring with implications for palliative and supportive care in addition to further investigation for cause.
Further detail as to whether physiological causes of fatigue such as anaemia or vitamin D deficiency were excluded or that it was confirmed as idiopathic with no identifiable cause. It is important to routinely screen for anaemia in this population of HCT survivors.
Sexual function was also a highly prevalent concern in our cohort with 14 (7 male, 7 female) reporting problems -such as early menopause and testosterone deficiency. Psychosexual functioning has been found to be worse in HCT patients compared with patients treated with chemotherapy alone and significantly worse compared with healthy subjects (Thygesen, Schjødt & Jarden, 2012) . The effect is long-lasting with survivors at increased risk of sexual function problems even 5-10 years after transplantation (Frey Tirri et al., 2015) . The late effects guidelines (Majhail et al., 2012) Tirri et al., 2015) . In men, gonadal function (particularly FSH, LH and testosterone) should be assessed if symptomatic eg lack of libido or erectile dysfunction. It is also important to rule out GVHD of the genital tract (Frey Tirri et al., 2015) . Once again systematic enquiry is indicated, even for intimate topics to allow patients permission to open a conversation and be reassured, itself considered therapeutic (Yi & Syrjala, 2009 
| CONCLUSION
In summary, this study described the population of 59 new patients to the late effects screening clinic with a mean 6 years since transplant. We demonstrated a high prevalence of systematic complications and evidence for further actions to assess these complications.
This new nurse-led screening clinics demonstrates clinical efficacy in identifying late complications using holistic screening and confirms the need for long-term follow-up post-transplantation (Hashmi, Carpenter, Khera, Tichelli, & Savani, 2015) . Ultimately, screening clinics such as this aim to pick up complications earlier to prevent/ reduce morbidity therefore playing a central role in optimising quality of life for HCT survivors. Future evaluation should more accurately assess the severity of each concern using a scoring system such as the Common Toxicity Criteria system (Trotti et al., 2003) .
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